Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Journal of Pain Research|June 3, 2021
Benefit-Risk Analysis of Buprenorphine for Pain ManagementMartin Hale, Mark Garofoli, Robert B Raffa
Substance Abuse and Rehabilitation|January 30, 2014
Naltrexone extended-release injection: an option for the management of opioid abuseRobert Taylor, Robert B Raffa, Joseph V Pergolizzi
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in miceRonald J Tallarida, Alan Cowan, Robert B Raffa
Brain Research|July 28, 2004
Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucoseSumiyo Umeda, Gregory W Stagliano, Robert B Raffa
Postgraduate Medicine|June 22, 2017
The effects of food on opioid-induced nausea and vomiting and pharmacological parameters: a systematic reviewRobert B Raffa, Robert Colucci, Joseph V Pergolizzi
Pharmacology, Biochemistry, and Behavior|February 20, 2007
An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2)Scott M Rawls, Teresa Gomez, Robert B Raffa
Drug and Alcohol Dependence|January 12, 2010
On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical dataRonald J Tallarida, Alan Cowan, Robert B Raffa
Expert Opinion on Pharmacotherapy|May 26, 2011
Extended-release formulations of tramadol in the treatment of chronic painJoseph V Pergolizzi, Robert Taylor, Robert B Raffa
Pageof 19